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Abstract
Background: Literature-based discovery (LBD) is characterized by uncovering hidden associations in non-interacting scientific
literature. Prior approaches to LBD include use of: 1) domain expertise and structured background knowledge to manually filter
and explore the literature, 2) distributional statistics and graph-theoretic measures to rank interesting connections and 3) heuristics
to help eliminate spurious connections. However, manual approaches to LBD are not scalable and purely distributional approaches
may not be sufficient to obtain insights into the meaning of poorly understood associations. While several graph-based approaches
have the potential to elucidate associations, their effectiveness has not been fully demonstrated. A considerable degree of a priori
knowledge, heuristics and manual filtering is still required.
Objectives: In this paper we implement and evaluate a context-driven, automatic subgraph creation method that captures
multifaceted complex associations between biomedical concepts for LBD. Given a pair of concepts, our method automatically
generates a ranked list of subgraphs, which provide informative and potentially unknown associations between such concepts.
Methods: To generate subgraphs, the set of all MEDLINE articles that contain either of two specified concepts (A, C) are first
collected. Binary relationships or assertions, which are automatically extracted from the MEDLINE articles, called semantic
predications, are then used to create a labeled directed predications graph. In this graph, a path is represented as a sequence of
semantic predications. The hierarchical agglomerative clustering (HAC) algorithm is then applied to cluster paths, which are
bounded by the two concepts (A, C) based on the definition of the context of a path, as a set of Medical Subject Heading (MeSH)
descriptors. Paths that exceed a threshold of semantic relatedness are clustered into subgraphs based on their shared context. The
automatically generated clusters are then provided as a ranked list of subgraphs.
Results: The subgraphs generated using this approach facilitated the rediscovery of 8 out of 9 existing scientific discoveries. In
particular, they directly (or indirectly) led to the recovery of several intermediates (or B-concepts) between A and C, while also
providing insights into the meaning of each association. Such meaning is derived from predicates between the concepts, as well as
the provenance of the semantic predications in MEDLINE. Additionally, by generating subgraphs on different thematic dimensions
(such as Cellular Activity, Pharmaceutical Treatment and Tissue Function), the approach enables a broader understanding of the
nature of complex associations between concepts in a domain. In a statistical evaluation to determine the interestingness of the
subgraphs, it was observed that an arbitrary association is mentioned in only approximately 4 articles in MEDLINE on average.
Conclusion: These results suggest that leveraging the implicit and explicit context provided by manually assigned MeSH de-
scriptors is an effective representation for capturing the underlying semantics of complex associations, along multiple thematic
dimensions for LBD.
Keywords: Literature-based discovery (LBD), Graph mining, Path clustering, Hierarchical agglomerative clustering, Semantic
Similarity, Semantic relatedness, Medical Subject Headings (MeSH)
1. Introduction
Leveraging rich representations of textual content from sci-
entific literature could be effective for finding and elucidating
∗Corresponding Author. Tel.: +1 937 775 5213; fax: +1 937 775 5133
Email address: delroy@knoesis.org (Delroy Cameron)
complex associations. Rich representations exploit implicit,
formal (or explicit) and powerful semantics [1] to capture con-
text, which may be important in providing deeper insights into
the nature of associations. Gordon and Dumais made this cru-
cial observation in [2] after successfully applying the popular
technique of Latent Semantic Indexing (LSI) for LBD. The au-
thors reported that LSI was only slightly more effective than
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traditional frequency-based metrics, such as token frequency,
record frequency and term frequency-inverse global frequency
(tf-igf) [3] for finding intermediates. While LSI was successful
for knowledge rediscovery, the authors speculated that richer
representations of textual content are needed to capture “ev-
idence suggestive of ‘causal’ relationships in the literature
(which may be revealed independently of their statistical promi-
nence).” Moreover, they stressed the need for “semantic and
category knowledge to improve the step of identifying [interme-
diate and] terminal concepts.”
Many techniques for finding hidden connections (or asso-
ciations) between biomedical concepts from scientific litera-
ture however, utilize frequency-based and graph-theoretic met-
rics. Few methods have been developed to seamlessly find and
elucidate complex associations, by going beyond reliance on
implicit semantics. The conventional wisdom has been that
discoveries are likely to arise from logical connections be-
tween source (A) concepts, intermediates (B) and targets (C)
that frequently or rarely (co) occur in the literature, or are
highly or rarely connected in a knowledge base. The earli-
est frequency-based approaches utilized ’frequency of occur-
rence’ mainly through measures of term (and concept) fre-
quency [4, 5]. Other measures such as relative frequency, token
frequency, term frequency-inverse global frequency (tf-igf) [3]
and term frequency-inverse document frequency (tf-idf) [6, 7]
were also used to rank intermediates. Subsequent approaches
utilized ’frequency of co-occurrence’ using techniques such as
LSI [2], association rules [8, 9, 10, 11] and probability distri-
butions [11, 12, 13, 14]. Torvik et. al. [12, 15] even used an
ensemble approach to find intermediates that combined statisti-
cal and temporal features.
While distributional approaches have been used for LBD, a
critical issue is the realization that the underlying frequencies
only provide an indirect way of capturing the meaning of asso-
ciations. For instance, consider the association in which Di-
etary Fish Oils (A) inhibit Platelet Aggregation (B) and the
aggregation of blood platelets causes Raynaud Disease (C); a
circulatory disorder that causes periods of severely restricted
blood flow to the fingers and toes [38]. While Dietary Fish Oils,
Platelet Aggregation, and Raynaud Disease may frequently co-
occur in the literature, their precise association is not explicitly
captured by their co-occurrence. A second issue is that the un-
derlying frequency distribution may not be adequate for cap-
turing related concepts, which may be important in elucidating
causal relationships and mechanisms of interaction.
To address these problems, several relations-based tech-
niques [16, 17, 18] have been developed, which use the explicit
relationships (or predicates) between concepts. Such predicates
are typically obtained from structured background knowledge
or known a priori by domain experts. For example, Hristovski
et. al. in [17], developed a relations-based approach that used
ordered alternating sequences of predicates and classes (or se-
mantic types) called discovery patterns. These patterns are also
specified a priori using insights from background knowledge.
Using discovery patterns, Hristovski argues that if a Disease
causes a change in a Substance/Body Function and a Drug in-
hibits this change, then the Drug MAYBE TREATS the Disease.
The CAUSES-INHIBITS sequence is used to uncover potentially
new Drug treatments for the Disease.
While intuitive, the relations-based approach is mainly ap-
plicable in scenarios where both predicates and semantic types
are known, or can be easily obtained. This is not always trivial.
For example, consider the complex scenario depicted in Figure
1, in which Dietary Fish Oils produce several Prostaglandins,
including Prostaglandin I3 (PGI3) and Epoprostenol (PGI2
also called Prostacyclin). The latter of these Prostaglandins
(Epoprostenol) treats Raynaud Syndrome and also disrupts
Platelet Aggregation. Since Platelet Aggregation causes Ray-
naud Syndrome one can reasonably conclude that a plausible
mechanism by which Dietary Fish Oils treat Raynaud Syn-
drome is through the production of Prostaglandins, which ac-
tively disrupt Platelet Aggregation, deemed a cause of Raynaud
Syndrome. Obviously such complex situations, involving sev-
eral predicates and disparate concepts may be unknown initially
by domain experts. The relations-based approach is therefore
considered unsuitable for complex associations.
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Figure 1: Complex association between Dietary Fish Oils and
Raynaud Syndrome
It can argued that hierarchical relations from the schema of
a domain specific knowledge base, such as the Unified Medical
Language System (UMLS) can also be used to create such com-
plex subgraphs, using measures like specificity. However, the
semantic types for Prostaglandins and Platelet Aggregation are
Eicosanoids and Cell Function, respectively. These semantic
types share no common ancestors in their lineage in the UMLS
Semantic Network1. And while associative relations can be
used instead, a proven and repeatable schema-driven approach
that captures this level of complexity has not been forthcoming.
Instead, contemporary approaches to LBD focus on creating
subgraphs, which comprise of binary relations, called seman-
tic predications, of the form (subject, predicate, object). These
predications are extracted directly from assertions in scientific
literature. Wilkowski et. al. [19] developed a graph-theoretic
approach based on semantic predications that iteratively (and
manually) uses a greedy strategy to create the best subgraph,
1There are three semantic types for Prostaglandins (i.e., Eicosanoid, Phar-
macologic Substance, and Biologically Active Substance) and one semantic
type for Platelet Aggregation (i.e., Cell Function) in the UMLS. These se-
mantic types do not overlap in the UMLS Semantic Network hierarchy –
https://uts.nlm.nih.gov/semanticnetwork.html
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Figure 2: Thematic dimensions of association for Raynaud Syndrome and Dietary Fish Oil
by weighting edges using degree centrality. This approach was
used to elucidate the association among Norepinephrine, De-
pression, and Sleep.
Wilkowski’s approach bears semblance to the approach by
Ramakrishnan et. al. [20], in which a greedy strategy is ap-
plied, using an ensemble of features, to generate complex asso-
ciations. While the approach is fully automatic, it uses class and
property specificity, instance-level rarity and refraction, applied
to statements in a synthetically generated dataset, instead of se-
mantic predications. Ramakrishnan notes that this approach
was used, in exploratory research, to recover the connections
from the Raynaud Syndrome – Dietary Fish Oils discovery.
However its broader applicability for LBD in general has not
been fully demonstrated. Reliance on hierarchical relationships
in the UMLS Semantic Network is subject to inconsistencies
since the UMLS is a terminology and not a formal ontology.
Also, by design, the trees in the UMLS Semantic Network are
fairly disjoint, as for Prostaglandins and Platelet Aggregation.
Goodwin et. al. [21] developed a hybrid approach that uses
spreading activation for LBD, deriving weights from relative
frequencies (of concepts and semantic predications) and de-
gree centrality. This approach was used to successfully recover
the intermediate Cortisol in the Testosterone – Sleep discov-
ery [22], and also to elucidate the Norepinephrine, Depression,
and Sleep scenario from [19]. However, Goodwin generates a
list of intermediates, instead of a graph. It is unclear how the
spreading activation algorithm might be adapted to capture the
context of complex associations. In [23] van der Eijk et. al.
clustered only MeSH2 descriptors (not semantic predications)
into subgraphs, based on frequency of co-occurrence and Heb-
bian Learning. This approach provided new insights into the
association between Deafness and Macular Dystrophy, and be-
tween Insulin and Ferritin. In recent work, Spangler et. al. [24]
also used distributional statistics (tf-idf) to weight edges in a ki-
nase network, represented as a Laplacian Matrix. The approach
creates an n-ary similarity tree in which 7 new p53 kinases were
discovered, which could revolutionize Cancer treatments.
In spite of the successes of graph-based and frequency-based
approaches for LBD, more effective methods for capturing the
context of associations are desired. Gordon and Dumais sug-
gested a possible independence between frequency and causal-
ity for LBD in [2]. We believe that complex associations that
elucidate the relationships among concepts depend both on im-
plicit and explicit context. Further, we believe that capturing
2Medical Subject Headings (MeSH) – https://www.nlm.nih.gov/mesh/
such context may be the important in segregating complex as-
sociations along multiple thematic dimensions. For example,
Figure 2 shows that Dietary Fish Oils and Raynaud Syndrome
are associated in at least the following three ways: 1) in terms
of Cellular Activity involving Blood platelets/Prostaglandins,
as shown in Figure 2a, 2) through Pharmaceuticals such as
Nifedipine and Verapamil, as shown in Figure 2b and 3) through
Lipids/Fatty Acids from Efamol and Evening primrose oil, as
shown in Figure 2c.
The approach for clustering of cliques developed by Zhang
et. al. [25, 26] may be used to capture subgraphs on multiple
thematic dimensions. However, the approach is based on degree
centrality and is therefore more likely to create subgraphs that
only consist of highly connected concepts from the literature.
In this paper, we explore the idea that hidden connections,
and their related concepts, which help elucidate underlying
complex associations, are more dependent on context than
frequency, connectivity or specificity.
This research builds on our previous approach in [27] in
which we rediscovered and decomposed the Raynaud Syndrome
– Dietary Fish Oils discovery by using domain expertise, as
context to manually create the subgraphs. Here, we present a
method to automatically create the subgraphs by gleaning im-
plicit and explicit context using MeSH descriptors. To achieve
this, we first specify the context of a semantic predication and
then use it to infer the context of a path. Such paths are then
clustered into coherent subgraphs on multiple thematic dimen-
sions, based on their shared context.
The approach requires only three items from the user as in-
put: 1) a list of concept labels for source (A) and target (C),
2) the maximum path length k of paths to be generated (default
k = 2, for ABC associations) and 3) a cut-off date dt for articles
to be included from the scientific literature. If no cut-off date
is provided all MEDLINE articles are used. The output of the
approach is a ranked list of subgraphs S .
To facilitate understanding the meaning of associations
present in the subgraphs, the predicates of the semantic predica-
tions and their provenance in MEDLINE are provided (see Sec-
tion 3). Relationships that are not explicit in the subgraphs, but
are inferred, can be explored by composing MEDLINE queries
(as we will show). The collective use of predicates, provenance
and MEDLINE queries for knowledge exploration constitute
the notion of discovery browsing3, introduced by Wilkowski
[19] and extended by Cairelli [28].
3Discovery browsing is enabled when a system guides the user through their
3
To assess the efficacy of our approach, two forms of evalu-
ation were conducted. An evidence-based evaluation showed
that the generated subgraphs could facilitate the rediscovery of
8 out of 9 existing discoveries [29, 30, 31, 32, 33, 34, 22, 28]. A
statistical evaluation to determine the interestingness of the sub-
graphs (discussed in Section 3.2) showed that an arbitrary as-
sociation occurs only in approximately 4 articles in MEDLINE
on average. This suggests that the subgraphs created using our
approach provide an effective way of finding and elucidating
poorly understood associations. In this paper we make the fol-
lowing specific contributions:
1. We develop a novel context-driven subgraph creation
method for closed LBD, capable of finding complex as-
sociations. Our approach is distinct from previous ap-
proaches, which are mainly based on statistical frequency,
graph metrics and specificity.
2. We implement an unsupervised clustering algorithm to au-
tomatically create complex subgraphs using implicit and
explicit context, without the need for complex heuristics
for filtering.
3. We illustrate the role of discovery browsing, through the
use of predicates and provenance to supplement the sub-
graphs with insights from the scientific literature.
4. We show the effectiveness of this approach in facilitating
the rediscovery of 8 out of 9 existing scientific discoveries.
The rest of this paper is organized as follows: The approach
to automatic subgraph creation is discussed in Section 2. Ex-
perimental Results are presented in Section 3 and a thorough
discussion on limitations and future work are presented in Sec-
tion 4. Conclusions are presented in Section 5.
2. Automatic Subgraph Creation
To automatically create complex subgraphs our approach re-
lies on three datasets. The first dataset is MEDLINE, which
is a repository of more than 23 million bibliographic citations
maintained by the National Library of Medicine (NLM). The
second is SemMedDB [35], a database of more than 65 mil-
lion semantic predications extracted from MEDLINE using
SemRep4. The third is the Biomedical Knowledge Reposi-
tory (BKR), a knowledge base consisting of statements from
the UMLS Metathesaurus together with semantic predications
extracted using SemRep. These components are used for auto-
matic subgraph creation in five steps: 1) Query Specification,
2) Candidate Graph Generation, 3) Path Context Representa-
tion, 4) Path Clustering and 5) Subgraph Ranking. Each step is
discussed in the following subsections:
exploration of the literature in a process of cooperative reciprocity. The “user
iteratively focuses system output, thus controlling the large number of relation-
ships often generated in literature-based discovery systems.”
4SemRep – http://semrep.nlm.nih.gov/
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Figure 3: System Architecture
2.1. Query Specification
The system (called Obvio5) first requires a query, denoted q,
which can be specified initially by providing the labels of two
concepts of interest (A, C). These terms are manually mapped
to concept unique identifiers (or CUIs), using the UMLS Se-
mantic Navigator6. For example, the A-term Dietary Fish Oil,
maps to the UMLS concept C0016157, whose label is also
Fish Oils. Initial A- and C-terms are also manually augmented
with other closely related concepts. For example, the con-
cepts Fish oil – dietary (C0016157) and Eicosapentaenoic Acid
(C0000545) are closely related to Fish Oils (C0016157) and are
therefore added to the query. Next, the cut-off date dt for the lit-
erature to be included may be optionally provided. If no cut-off
date is given the system uses the entire MEDLINE database.
The maximum path length k, of paths to be generated between
A and C may then also be optionally provided. If none is given,
the system defaults to a maximum path length of k = 2. An ex-
ample query for Raynaud Syndrome – Dietary Fish Oils could
be q = ({Fish Oils, Fish oil – dietary, Eicosapentaenoic Acid},
{Raynaud Phenomenon, Raynaud Disease}, 11/01/1985, 3).
2.2. Candidate Graph Generation
Given this query q = (A,C, dt, k), the Query Processor (Fig-
ure 3, top left) then retrieves the set of MEDLINE documents D
that contain any of the terms (i.e., labels) in the A- and C- sets.
These documents form the corpus from which semantic predi-
cations will be obtained. To obtain the predications, the set of
PubMed identifiers (or PMIDs) for each article in D is passed
to the Predications Graph Builder, which creates a labeled di-
rected graph, called a predications graph denoted G. To achieve
this, the graph builder collects the semantic predications for
each document in D that are also present in SemMedDB. The
builder then creates a graph in which nodes are UMLS concepts
5Obvio video demo - http://bit.ly/obviodemo, Obvio Project page -
http://wiki.knoesis.org/index.php/Obvio
6Semantic Navigator – http://mor2.nlm.nih.gov:8000/perl/auth/semnav.pl
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and edges are UMLS predicates. This graph is delivered as in-
put to the Subgraph Generator, which first uses the Path Gen-
erator to extract all paths between (A, C) up to length k, using
the Depth First Search (DFS) algorithm. DFS is selected be-
cause both A and C are known. However, the choice of Breadth
First Search (BFS) may be equally effective for graph traversal,
but has not been explored, since performance is not the primary
focus. The path generator therefore uses the predications graph
to produce paths (or ρ-path associations), where edges are ori-
ented in either direction, consistent with our definition in [27].
This restricted set of paths is called the reachability relation R
[36] (or candidate graph) between A and C at length k and date
range dt. This candidate graph represents a more likely set from
which discoveries may arise.
2.3. Path Context Representation
The candidate graph is then provided as input to the Path
Clustering Module, which requires a definition for the context
of a path p to cluster related paths into subgraphs. To specify
path context, denoted C(p), we first specify the context of a se-
mantic predication t, denoted c(t). The context of each predica-
tion in the path is then aggregated to obtain overall path context.
To define the context of a semantic predication, we make two
assumptions, based on observations about MEDLINE articles.
The first observation is that MeSH descriptors are manually as-
signed to MEDLINE articles (titles and abstract only) by MeSH
indexers, based on human interpretation of the meaning of the
entire article. These descriptors provide a concept-level seman-
tic summary of the full text. Similarly, semantic predications
also provide a semantic summary of the meaning of the con-
tent. However, semantic predications provide a relational se-
mantic summary, by linking concepts using explicit predicates.
We therefore assume that the MeSH descriptors of an arti-
cle capture its implicit context, which is shared by the semantic
predications. A semantic predication can then be represented in
terms of the MeSH descriptors of the article in which the pred-
ication occurs. This is the basis for our interchangeability as-
sumption for subgraph creation, which states that the concept-
level semantic summary and relational semantic summary of
a MEDLINE article, are interchangeable. More specifically,
given a semantic predication t and a MEDLINE article d such
that t is extracted from d, the context of the semantic predica-
tion c(t) = M(d), where M(d) is the set of MeSH descriptors
assigned to d.
If this assumption holds, then we can make a second assump-
tion, which is that the overall context of a semantic predication t
across the entire corpus can be represented as a vector of MeSH
descriptors aggregated from each document containing t (based
on distributional semantics). This is the basis for our context
distribution assumption for subgraph creation, which states
that the context of a semantic predication can be expressed as
the distribution of all MeSH descriptors associated with all ar-
ticles that contain the predication.
Since our fundamental premise for subgraph creation is that
relatedness among concepts is independent of statistical fre-
quency, graph metrics or specificity, our vector representation is
downgraded to the Boolean-valued set representation, in which
a MeSH descriptor is either present or absent in the distribution.
The context of a path
C(p) =
⋃
t∈p
c(t) (1)
is therefore the aggregation of its predication context sets.
2.4. Path Clustering
The Path Clustering Module uses the context set C(p) for
each path p in the candidate graph R to cluster related paths pi
and p j, based on their shared context. To compute this shared
context between paths, the system initially computes the inter-
section s′′(pi, p j) = C(pi)∩C(p j) of their shared MeSH descrip-
tors. However, to account for inexact matches between MeSH
descriptors across the two sets, this intersection is enhanced us-
ing the MeSH hierarchy, which provides explicit (or formal) se-
mantics. Specifically, we use the Cartesian product of the two
context sets C(pi) × C(p j) to determine which pairs of MeSH
descriptors adequately indicate relatedness between the paths.
Pairs of descriptors (mi,m j), whose similarity is above some
threshold of MeSH semantic similarity are retained, while those
below are discarded. The key idea is to maximize the weights
of the in-context descriptors and minimize the weights of the
out-of-context descriptors.
To compute semantic similarity between MeSH descriptors
the measure of dice similarity is used. Dice similarity computes
the proportion of common ancestors between descriptors in the
MeSH hierarchy (MH). For two MeSH terms mi and m j the dice
similarity is computed as
dice(mi,m j) = 2 ×
|ancestors(mi)MH ∩ ancestors(m j)MH |
|ancestors(mi)MH | + |ancestors(m j)MH |
,
(2)
where ancestors(mi)MH is the set of all ancestors of mi in
MeSH. The maximum similarity between two descriptors com-
puted using dice similarity is 1. This occurs when the descrip-
tors are equal. (i.e., mi = m j). The range of similarity values is
therefore [0,1].
In this computation, pairs of descriptors, whose dice similar-
ity exceed the threshold of semantic similarity (τsim = 0.75) are
normalized to a value of 1. This normalized dice similarity
diceN(mi,m j) =
1 if dice(mi,m j) > τsim0 otherwise (3)
is therefore computed conditionally. The initial overall seman-
tic relatedness
sr′′(pi, p j) =
∑
(a,b)∈C(pi)×C(p j)
diceN(a, b) (4)
between pi and p j is the sum of the normalized pairwise dice
similarity scores that exceed the threshold of semantic similar-
ity, across the context sets C(pi) ×C(p j).
A consequence of this semantics-enhanced shared context,
is that a broad range of relatedness scores may exist. Paths that
are very similar, which have many exact (and inexact) MeSH
5
descriptors in common will have very scores, while others may
have low scores. To dampen the major differences in similarity
scores of different path pairs, we apply a log reduction on the
normalized dice similarity scores. This is achieved by first com-
puting the relatedness score between a given MeSH descriptor
a in context set C(pi) against the entire set of descriptors in the
context set C(p j). This computation yields the similarity score
sim′(a,C(p j)) =
∑
b∈C(p j)
diceN(a, b). (5)
The log reduction
sr′′L (pi, p j) =
∑
a∈C(pi)
log
(
1 + sim′(a,C(p j))
)
(6)
is then applied to sim′(a,C(p j)), and the overall semantic relat-
edness sr′′(pi, p j) between the two paths is the aggregate of the
log-reduced scores for each descriptor in C(pi) and the entire
set in C(p j). This metric is the basis for finding and elucidating
complex associations among concepts, along multiple thematic
dimensions, based on implicit and explicit context, alluded to
by Gordon and Dumais in [2].
In the next step the hierarchical agglomerative clustering
(HAC) algorithm is used to create subgraphs by clustering re-
lated paths. In the bucket population step, the algorithm initial-
izes |R| buckets, one for each path in the candidate graph. For a
given path, the relatedness score is computed for each of the re-
maining |R| − 1 paths. If two paths are sufficiently related, they
must be placed in the same cluster. To achieve this, a method
to automatically determine the threshold for path relatedness
denoted τrel, is required.
To obtain the threshold for path relatedness the distribution of
path relatedness scores between all pairs of paths in the candi-
date graph is pre-computed (i.e., (|R|× |R−1|)/2 scores). Figure
4 shows the distribution of relatedness scores for three exper-
iments in the initial stages of our research. Each distribution
approximates to a Gaussian (or normal) distribution.
Table 1: Threshold Comparisons
Scenario Path Relatedness Scores Max
2 Std. Dev Manual 3 Std. Dev.
Raynaud-Fish Oil 2.68 3.0 3.04 3.38
Testosterone-Sleep 3.35 3.5 3.83 6.22
DEHP-Sepsis 3.94 4.0 4.53 4.84
In statistics, the first standard deviation (−σ,+σ) from the
mean of a Gaussian distribution corresponds to the point of in-
flection. This point likely indicates a shift in a trend or phe-
nomenon. When the manually determined thresholds for path
relatedness for the same three experiments were compared to
the σ, 2σ and 3σ of the Gaussian distribution, it was observed
that the manual thresholds were consistently between the 2σ
and 3σ, as shown in Table 1. The second deviation from the
mean of the Gaussian distribution (τrel = 2σ) was therefore
selected as the path relatedness threshold for clustering. Dur-
ing clustering, all pairs of paths with relatedness scores above
this automatically determined threshold were added to the same
cluster.
In the next phase of HAC (bucket merging), buckets that con-
tain multiple paths are merged if their inter-cluster similarity
exceeds the threshold for path relatedness. That is, for each
pair of paths (pi, p j) across a pair of buckets Ba and Bb, the
inter-cluster similarity
siminter(Ba, Bb) =
∑
(pi,p j)∈Ba×Bb
sr′′L (pi, p j)
|Ba| · |Bb|
, (7)
was computed as the sum of the semantic relatedness scores,
normalized by the sizes of the two buckets. The clustering al-
gorithm terminated when the number of clusters between suc-
cessive iterations remained unchanged.
2.5. Subgraph Ranking
The generated subgraphs are then ranked. Subgraphs con-
taining more than one path are ranked in descending order,
based on their intra-cluster similarity, which measures the com-
pactness of the cluster. To compute this measure
simintra(B) =
2 ·
∑
pi,p j∈B, pi,p j sr
′′
L (pi, p j)
|B| · (|B| − 1)
, (8)
the aggregate of the relatedness score for each pair of paths
(pi , p j) in a given cluster B is obtained and then normalized.
Singleton clusters consisting of only one path were ranked in
ascending order using the measure of association rarity. That
is, given a path pi, an association A(pi), derived of the path,
is the set of unique concepts in the path. Association rarity is
the number of MEDLINE articles f (A(pi)) that contain only the
concepts in the path. For singleton paths, bucket rarity
r(B) =
∑
pi∈B f (A(pi))
|B|
(9)
is the same as association rarity, since B = {pi}.
The ranked list of clusters is rendered to the user for
inspection in the Discovery Browsing Interface. This in-
terface is available for review online (live tool – http:
//knoesis-hpco.cs.wright.edu/obvio/, video demo –
http://bit.ly/obviodemo). Concepts are color-coded
based on semantic groups obtained from the BKR, while pred-
icates are color-coded based on a locally developed coding
scheme, since none exists for predicates in the BKR.
Using this approach, 8 out of 9 existing scientific discoveries
were recovered. These well-known discoveries are: 1) Raynaud
- Fish Oil (1986) [29], 2) Magnesium - Migraine (1988) [30],
3) Somatomedin C - Arginine (1990) [31], 4) Indomethacin -
Alzheimer’s Disease (1996) [32], 5) Estrogen - Alzheimer’s Dis-
ease (1996) [33] 6) Calcium-Independent Phospholipase A2 -
Schizophrenia (1998) [34], 7) Chlorpromazine - Cardiac Hy-
pertrophy (2004) [14], 8) Testosterone - Sleep (2012) [22] and
9) Diethylhexyl (DEHP) - Sepsis (2013) [28]. In the next sec-
tion the application of this approach for the rediscoveries is dis-
cussed.
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Figure 4: Gaussian Distribution of Path Relatedness scores for three rediscovery scenarios
3. Experimental Results
Given the absence of a gold standard dataset in LBD re-
search, knowledge rediscovery is considered a de facto stan-
dard for evaluating LBD systems. To assess the effectiveness
of the context-driven subgraph method, both an evidence-based
evaluation and a statistical evaluation were conducted, based on
nine existing scientific discoveries. The evidence-based evalua-
tion qualitatively determines the extent to which our approach is
capable of rediscovering the known knowledge, while the sta-
tistical evaluation is intended to measure the likelihood that a
domain expert might be motivated to explore an arbitrary sub-
graph generated by the system. Specifically, it measures the
interestingness of a subgraph, by quantifying the rarity of asso-
ciations in the subgraphs in MEDLINE. Associations that have
never been mentioned in any MEDLINE article are considered
most interesting and are called zero-rarity associations (ZR).
The obvious caveat is that rare associations are not necessarily
all interesting. The next section discusses the evidence-based
evaluation.
3.1. Evidence-Based Evaluation
The first aspect of the evidence-based evaluation reports on
the number of intermediates from a discovery that could be
retrieved by our system. The second aspect substantiates the
meaning of each association using evidence from the litera-
ture. Such evidence can be derived first using the predicates
of the semantic predications in the subgraph. However, when
this is insufficient or contradictory, evidence is obtained using
the provenance of the predications in MEDLINE. Additionally,
queries can be composed and executed in PubMed to explore
inferred associations, not explicitly stated in the subgraphs, as
commonly practiced.
For each rediscovery scenario, no concept filters were speci-
fied, to exclude concepts based on semantic types or groups. A
generic predicate filter, called the STRICT filter was applied uni-
formly by the system (not the user), across some experiments,
to exclude less informative UMLS predicates, such as ASSOCI-
ATED WITH, INTERACTS WITH and AFFECTS. This limited degree
of manual filtering is the extent of a priori knowledge required
for subgraph generation in the system. Also, in the following
tables, the letter Y (for yes) is used to indicate that the status
S of an intermediate as ‘found directly in a subgraph at posi-
tion P in the list of subgraphs. The symbol Y∗ indicates that an
intermediate was found through discovery browsing.
Due to space limitations, only three experiments are dis-
cussed in detail: 1) Raynaud - Fish Oil, 2) Magnesium - Mi-
graine and 3) Somatomedin C - Arginine. The six remaining
experiments are discussed briefly in Section 3.1.4. Further de-
tails on each experiment are available in [43] and in the follow-
ing online supplementary materials: 1) the Obvio wiki page
- (http://wiki.knoesis.org/index.php/Obvio, section
on Automatic Subgraph Creation), 2) a video demo - http:
//bit.ly/obviodemo and 3) a beta-version of the Obvio
web application - http://knoesis-hpco.cs.wright.edu/
obvio/. The next section discusses the application of our ap-
proach to rediscover the Raynaud - Fish Oil rediscovery.
3.1.1. Raynaud Syndrome – Dietary Fish Oils
In November 1985, American Information Scientist Don R.
Swanson (1924 – 2012) explored the research question of the
role of Dietary Fish Oils (from salmon, mackerel, albacore,
etc.) in Raynaud Syndrome. Through the methods described
in [29], Swanson discovered that “dietary fish oil might ame-
liorate or prevent Raynaud’s syndrome.” This is because Di-
etary Fish Oils: 1) inhibit Platelet Aggregation, 2) increase the
flow of blood (by reducing Blood Viscosity) and 3) also have
a regulatory effect on the smooth muscle (thereby preventing
Vasoconstriction and stimulating Vasodilation). Each of these
concepts is causally implicated in Raynaud.
We seeded our algorithm with three concepts as sources: 1)
Fish Oils (C0016157), 2) Fish oil - dietary (C0556145) and 3)
Eicosapentaenoic Acid (C0000545) and two concepts as tar-
gets: 1) Raynaud Disease (C0034734) and 2) Raynaud Phe-
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nomenon (C0034735). The corpus consisted of the relevant
61 full text articles discussed by Swanson [29] in the pre-
November 1985 period. There were only 4 articles from the
Dietary Fish Oil set, which were in the Raynaud set. The path
length was set to 3 and no predicate filter was specified. These
choices are consistent with the choices in our earlier experi-
ments in [27], in which we rediscovered and decomposed this
hypothesis by manually constructing the subgraphs, using do-
main expertise as context.
Figure 5: Subgraph1 (k = 3, 3σ) on Eicosapentaenoic Acid,
Platelet Aggregation and Raynaud Syndrome
The algorithm terminated in less than 5 minutes, producing
4 subgraphs (and 134 singletons) at 2σ and one subgraph (and
164 singletons) at 3σ. There were 1035 unique concepts and
4143 unique predications in the predications graph and the can-
didate graph contained 171 paths of length 3. Figure 5 shows
that at 3σ, subgraph1 directly contains the intermediate Platelet
Aggregation, which many rediscovery approaches consider suf-
ficient to constitute a rediscovery. However, to better substan-
tiate the association, we utilize the predicates in the subgraph,
together with the provenance of the predications in MEDLINE,
along with traditional PubMed search, to provide evidence.
The predication, which states that [Eicosapentaenoic Acid
CONVERTS TO Prostaglandins] was extracted from the fol-
lowing corroborating sentence, in the full text of the follow-
ing article [PMID6827988] by Harris et. al. The authors
state that the “recent discovery that the prostaglandins derived
from eicosapentaenoic acid have biological effects different
than those derived from arachidonic acid (C20:4w6) has gen-
erated further interest in fish oils.” Two of the other 61 articles
[PMID6321621, PMID6314583] contained this predication.
Harris also refers to the 1979 article [PMID218223] by Needle-
man et. al., which suggests further that [Eicosapentaenoic Acid
CONVERTS TO Prostaglandin (PGI3)] in its metabolic path-
way. And the full text of 1985 article [PMID2997286] by von
Schaky et. al. confirms that Eicosapentaenoic Acid produces
Prostaglandin (PGI3) and Epoprostenol (Prostacyclin (PGI2)).
von Schaky notes that “dietary EPA is transformed in vivo in
humans into prostaglandins I3, which is as active . . . as the va-
sodilatory and antiaggregatory prostaglandin I2.”
The subgraph also contains the predication, which states
that [Eicosapentaenoic Acid DISRUPTS Platelet Aggregation].
This predication was extracted from the full text of the article
[PMID6320840] by Saynor et. al., who refers to the “Mecha-
nisms underlying the inhibition of platelet aggregation by eicos-
apentaenoic acid and its metabolites.” The predication [Al-
prostadil DISRUPTS Platelet Aggregation] was extracted from
the full text of the article [PMID6302714] by Dyerberg et. al.,
who pointed out that another author7 “was the first to show that
[Prostaglandin E1] PGE1 inhibited platelet aggregation.” The
previously article by von Schaky also alludes to this possibility.
Conversely, the predication [Epoprostenol TREATS Ray-
naud’s Phenomenon] was correctly extracted from two articles;
by Dowd et. al. [PMID7037038], who discusses “Treatment of
Raynaud’s phenomenon by intravenous infusion of prostacyclin
(PGI2)” and by Belch et. al. [PMID3883365], who discusses
“Increased prostacyclin metabolites and decreased red cell de-
formability in patients with systemic sclerosis and Raynauds
syndrome.” Since both Alprostadil (PGE1) and Epoprostenol
(PGI2) are synthetic forms of Prostaglandins, it is plausible
that both Alprostadil and Epoprostenol actually treat Raynaud’s
Syndrome by disrupting Platelet Aggregation. Indeed, the 1982
article [PMID6890719] by Pardy et. al., obtained through
a date-restricted MEDLINE query8, confirms that Alprostadil
(PGE1) treats Raynaud Phenomenon, instead of the weaker IN-
TERACTS WITH relationship, present in the subgraph. The
role of Platelet Aggregation in causing Raynaud, which is in-
ferred and not explicit in the subgraph, is easily confirmed us-
ing another MEDLINE query (Platelet Aggregation AND Ray-
naud AND 1865:1985/11[DP]), which yields the 1985 article
[PMID3985417] by Soro et. al.
This subgraph together with discovery browsing suggest
a richer relationship among Eicosapentaenoic Acid, Platelet
Aggregation and Raynaud Syndrome than would be provided
by their co-occurrence. Rather, it appears that one mecha-
nism by which [Eicosapentaenoic Acid TREATS Raynaud Syn-
drome] is by stimulating a series of Prostaglandins (namely,
Prostaglandin I3 (PGI3), Prostaglandin E1(PGE1) and Prosta-
cyclin (PGI2)), which actually disrupt Platelet Aggregation.
An important observation is that the subgraph contains con-
tradicting semantic predications. For example, the two predica-
tions [Eicosapentaenoic Acid CONVERTS TO Prostaglandins]
and [Eicosapentaenoic Acid INHIBITS Prostaglandins] are op-
posing. The full text of the article [PMID6827988] by Harris et.
al., from which the predication [Eicosapentaenoic Acid CON-
VERTS TO Prostaglandins] was extracted supports its claim.
However, the full text of the lone article [PMID6301111] by
Moncada from which the predication [Eicosapentaenoic Acid
INHIBITS Prostaglandins] was extracted states that “It is clear,
therefore, that both prostaglandin dependent and independent
pathways of platelet aggregation are inhibited by EPA in vitro.”
This is an incorrect extraction from SemRep. The author is
noting that [Eicosapentaenoic Acid INHIBITS Platelet Aggre-
gation], not Prostaglandins as the predication suggests. It is
important to note that resolution of such discrepancies is part
7Kloeze, J. Prostaglandins, Proceedings of the 2nd Nobel Symposium, pp.
241-252 (BERTSTR(iM, S. and SAMUELSON, B., eds.) Almqvist and Wik-
sell, Stockholm, 1967.
8Query: Alprostadil AND Raynaud AND 1865:1985/11[DP] . Confirmed in
search result #12
8
of the discovery browsing process, which requires adjudication
by domain experts. We provide the infrastructure for achieving
this through provenance.
The second intermediate Blood Viscosity, was found in the
list of zero-rarity singletons (result #15 in Table 2). The ac-
tual singleton, which states that [Eicosapentaenoic Acid DIS-
RUPTS Blood Viscosity], [Ketanserin DISRUPTS Blood Viscos-
ity], [Ketanserin TREATS Raynaud Disease], suggests a causal
relationship between Blood Viscosity and Raynaud Syndrome.
This inferred relation that [Blood Viscosity CAUSES Raynaud
Syndrome] is confirmed in the 1984 article [PMID6707529] by
Larcan et. al through a MEDLINE search. The statement [Ke-
tanserin DISRUPTS Blood Viscosity] is verified in the following
articles [PMID401574], [PMID6303363] and [PMID2412054].
Likewise, the predication [Ketanserin TREATS Raynaud Dis-
ease] can be verified in the article [PMID6432198] by Roald
et. al. and also [PMID6209510] by Bounameaux et. al.
Table 2 shows the number of intermediates rediscovered for
this experiment compared with 4 other approaches. The inter-
mediate Vascular Reactivity (in reference to Vasoconstriction)
was not found explicitly by our approach (although can be in-
ferred from the article [PMID2997286] by von Schacky et. al.).
This is not completely unexpected, since it is known from our
reports in [27] that SemRep interprets “Vascular” and “Reac-
tivity” as separate concepts. Hristovski in [17] was also subject
to the same limitation.
Srinivasan [7] found all three intermediates in the top 2 of
the top 30. However, note that Srinivasan’s approach relies on
a priori knowledge of the semantic types of the intermediates
for filtering and is manually intensive. Additionally, that ap-
proach does not create complex subgraphs, nor does it provide
evidence for the meaning of associations using predicates. Hris-
tovski et. a.l. [17] and Weeber et. al. [4] also require consider-
able domain expertise, particularly for specification of a priori
relations (i.e., semantic types and discovery patterns). Gordon
and Lindsay [6] find intermediates but make no attempt to elu-
cidate the meaning of associations.
Figure 6: Subgraph1 (k = 3, 2σ) on Dietary Fish Oils - Ray-
naud Syndrome (Blood Platelets/Prostaglandins)
To illustrate that our subgraphs capture different thematic di-
mensions of association between two concepts, consider the
four subgraphs at 2σ. Subgraph1 in Figure 6a is similar to sub-
graph1 (at 3σ) except that it includes the three additional in-
termediates, TIMP1, TIMP1 protein, human and Thromboem-
bolism. This is naturally due to a lower threshold for path
relatedness. By inspection, this subgraph elucidates the as-
sociation between Dietary Fish Oils and Raynaud Syndrome
through Blood Platelets/Prostaglandins, similar to the previous
subgraph.
Figure 7: Subgraph2 (k = 3, 2σ) on Dietary Fish Oils - Ray-
naud Syndrome (Pharmaceuticals)
Subgraph2 (shown in Figure 7) associates Dietary Fish Oils
and Raynaud Syndrome from the perspective of Pharmaceu-
ticals, including Nifedipine, Pentifylline, Thyrocalcitonin, and
Trinitrin detailed especially in the article [PMID6352267] by
Kahan et. al., from which the predication [Nifedipine TREATS
Raynaud Phenomenon] was extracted. Epoprostenol is the syn-
thetic form of Prostacyclin (PGI2).
Figure 8: Subgraph3 (k = 3, 2σ) on Dietary Fish Oils - Ray-
naud Syndrome (Lipids/Fatty Acids)
Subgraph3 in Figure 8 discusses the role of various
Fatty Acids, which associate TIMP1, Epoprostenol, Efamol
and Evening Primrose (see [PMID4082084, PMID6318123,
PMID6321621]).
Figure 9: Subgraph4 (k = 3, 2σ) on Eicosapentaenoic Acid,
Platelet Aggregation and Raynaud Syndrome (Blood Platelets)
Subgraph4 in Figure 9, which focuses more on Cellular Ac-
tivity at the level of Blood Platelets involving Thromboem-
bolism, is subsumed by subgraph1. Currently, subgraph sub-
sumption has not been addressed in this work and remains a
system limitation, discussed in Section 4. In the next section,
the Migraine - Migraine experiment is discussed.
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Table 2: Comparison of rediscoveries with other approaches for Raynaud Syndrome - Dietary Fish Oils
Scenario Intermediate(s)
Cameron Srinivasan [7] Weeber [4] Gordon [3] Hristovski [17]
S P S P S P S P S P
Raynaud Syndrome - Dietary
Fish Oils
Blood Viscosity Y* ZR-15 Y 2 Y – Y 5 Y 8
Platelet Aggregation Y 1 Y 1 Y – Y 6 Y 17
Vascular Reactivity – – Y 1 Y – Y 19 – –
3.1.2. Magnesium – Migraine
In August 1987, Swanson explored the research question of
the role of Magnesium in Migraine Disorder. Through the
methods described in [30] he discovered 11 neglected connec-
tions between Magnesium and Migraine. He found that Mag-
nesium deficiency might exacerbate Migraine due to compli-
cations involving Stress (Type A personality), Spreading Corti-
cal Depression, Epilepsy, Platelet Aggregation, Serotonin, Sub-
stance P, Inflammation, Vasoconstriction, Prostaglandin forma-
tion and Hypoxia. Also, as a natural calcium channel blocker,
Magnesium may further prevent Migraine attacks.
We seeded our algorithm with Magnesium (C0024467) as
the source and Migraine Disorders (C0149931) as the target.
The path length was 2 and no predicate filter was used, to be
more consistent with the discovery. The corpus consisted of
more than 47,000 articles from the pre-August 1987 period (i.e.,
41,507 abstracts on Magnesium and 6,171 on Migraine, 7 over-
lapping). There were 14697 unique concepts, 73,960 predica-
tions in the predications graph and 256 distinct paths of length
2 in the candidate graph. The algorithm terminated in less than
one hour, producing 25 subgraphs (and 151 singletons) at 2σ
and 6 subgraphs (and 231 singletons) at 3σ.
Figure 10: Subgraph1 (k = 2, 2σ) Magnesium - Migraine
It was known from the 1973 article [PMID4725298] by Vos-
geru (one of the 7 overlapping) that Magnesium Glutamate was
used to treat Migraine. Figure 10 shows that the intermedi-
ate Serotonin was found in subgraph1 at 2σ. The lone arti-
cle [PMID3629724] by Pertseva et. al. from which the pred-
ication [Magnesium INTERACTS WITH Serotonin] was ex-
tracted, is inconclusive. According to Swanson this associa-
tion should be that [Magnesium INHIBITS Serotonin]. The ar-
ticle [PMID3512233] by Houston et. al. from which the pred-
ication [Serotonin CAUSES Migraine] was extracted (among
three others), suggests that elevated levels of Serotonin can in-
duce Vasoconstriction, which causes Migraine. Houston ex-
plicitly states that “much evidence has implicated serotonin (5-
hydroxytryptamine) in the pathogenesis of migraine.” The arti-
cle further notes that Serotonin is released from Platelet Aggre-
gation and might reach sufficient levels to exacerbate Migraine,
as noted by Swanson. The 1987 article [PMID2440758] by
Briel et. al. (through a MEDLINE search) confirms that Mag-
nesium inhibits Platelet Aggregation. It follows that elevated
Magnesium levels may inhibit both Serotonin and Platelet Ag-
gregation, and so treat Migraine.
Figure 11: Subgraph4 (k = 2, 2σ) Magnesium - Migraine
Figure 11 shows subgraph4, which contains the intermediate
Prostaglandins between Magnesium and Migraine. The lone
article [PMID3871957] by Friedlander et. al. from which the
predication [Prostaglandins INTERACTS WITH Magnesium]
was extracted, suggests a decrease in prostaglandin synthe-
sis is accompanied by lower levels of magnesium (and cal-
cium). This is based on the title: “Decreased calcium and
magnesium urinary excretion during prostaglandin synthesis
inhibition in the rat” as noted by Swanson. The 1986 arti-
cle [PMID3016750] by Nigam et. al. confirms that [Mag-
nesium STIMULATES Prostaglandins] as suggested by Swan-
son. The article [PMID89390] by Hakkarainen et. al. from
which the predication [Prostaglandins ASSOCIATED WITH
Migraine Disorders] was extracted (among only three others)
states that “Tolfenamic acid (a potent inhibitor of prostaglandin
biosynthesis) was effective in treating acute migraine attacks.”
The specific role of Prostaglandins in Migraine was unclear
however, even after discovery browsing. Swanson suggested
that [Prostaglandins INHIBITS Migraine].
Figure 12 shows that the intermediate Vascular Disease
was found explicitly in subgraph9. The title of the article
[PMID4260015] by Wustenberg et. al. from which the predica-
tion [Magnesium ASSOCIATED WITH Vascular Disease] was
extracted, suggests a role for magnesium in vascular reactivity.
The title of the article reads in part, “. . . Findings in magne-
sium metabolism in vascular diseases.” Similar to the predi-
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Table 3: Comparison of rediscoveries with other approaches for Magnesium - Migraine
Scenario Intermediate(s)
Cameron Srinivasan [7] Weeber [4] Blake [37] Gordon [3]
S P S P S P S P S P
Magnesium - Migraine
Calcium Channel Blockers Y 22 Y 3 Y – Y 10 Y 1
Epilepsy Y* 9 – – Y – Y 8 Y 3
Hypoxia – – Y 5 – – Y 6 Y 77
Inflammation Y* ZR-3 Y 2 Y – Y 170 Y 82
Platelet Activity Y* 1 Y 2 Y – Y 2 Y 8
Prostaglandins Y 4 Y 1 Y – Y 42 Y 27
Type A Personality – – Y 1 Y – Y 23 – –
Serotonin Y 1 Y 1 Y – Y 5 Y 1
Cortical Depression – – Y 6 – – Y 45 – –
Substance P – – Y 18 Y – Y 38 Y 23
Vascular mechanisms Y 9 Y 1 Y – Y 46 Y 16
Figure 12: Subgraph9 (k = 2, 2σ) Magnesium - Migraine
cation with Serotonin, it is unclear from this title that [Mag-
nesium INHIBITS Vasoconstriction] as noted by Swanson. On
the other hand, the article [PMID1153064] by Domzal, from
which the predication [Migraine Disorders ISA Vascular Dis-
eases] was extracted (among three others), suggests that mi-
graine is also a vascular disorder, although primarily a cere-
bral disorder. The lone article [PMID3945397] by Coppeto et.
al. from which the predication [Migraine Disorders AFFECTS
Vascular Diseases] was extracted provides more compelling
evidence by linking migraine and vascular retinopathy as sug-
gested by Swanson. Coppeto reported that “two migraineurs
suffered sudden, persisting loss of vision from retinal vascular
occlusion.” This effect is consistent with the observation by
Houston et. al. from the article [PMID3512233] on Serotonin
from subgraph1. Salati et. al. in [PMID6225285], from which
the predication [Migraine Disorders ISA Vascular Diseases]
was extracted, noted a dependency among Migraine, Vascular
diseases, Epilepsy and Autoscopy (outer-body hallucination).
The two calcium channel blockers, Nifedipine and Verapamil
were the only intermediates in subgraph22 (not shown). All
three articles [PMID2425960, PMID3673084, PMID6539877]
confirmed that these calcium channel blockers treat Migraine
as suggested by Swanson. The article [PMID537283] by
Khoda et. al. from which the predication [Verapamil INTER-
ACTS WITH Magnesium] was extracted suggested that Magne-
sium inhibits Verapamil as noted by Swanson.
The intermediate Hydrocephalus (accumulation of fluid in
the brain), which leads to Brain Edema (referred to as or in-
flammation by Swanson), was found among the zero-rarity as-
sociations (see Table 3). The remaining intermediates Hypoxia,
Spreading Cortical Depression, Stress (Type A Personality) and
Substance P were not found among the subgraphs.
Interestingly, only subgraph22 on the calcium channel block-
ers was a complex subgraph in which existing knowledge was
recovered. While several intermediates related to Vascular Re-
activity, such as Vasospasm, Vascular Function, Vasoconstric-
tion and Vascular Disease exists, their shared context did not
meet our threshold for path relatedness and hence they were not
grouped into the same cluster. The shortcomings of SemRep in
extracting Vascular Reactivity may also have been a limiting
factor. Still, altogether 10 out of the 25 subgraphs contained
complex associations.
Figure 13: Subgraph7 (k = 2, 2σ) Magnesium - Migraine
Subgraph7 (shown in Figure 13) for example, links Theo-
phylline and Caffeine, with Magnesium and Migraine, which
have different semantic types, but belong to the general group
of Stimulants. Subgraph6 (not shown) associates Epinephrine
and Glucose from the perspective of Metabolism. Table 3 shows
that ultimately, 7 out of the 11 associations found by Swanson
could be found using our approach.
3.1.3. Somatomedin C – Arginine
In April 1989, Swanson explored the research question
of the role of the dietary amino acid Arginine, in Growth
along with the protein Somatomedin C (also called Insulin-Like
Growth Factor 1 (IGF1)). Through the methods discussed in
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[31], Swanson discovered 4 implicit connections between So-
matomedin C and Arginine. He found that Arginine intake
could: 1) stimulate Growth and protein synthesis, 2) promote
Wound Healing and cell regeneration, 3) facilitate nutritional
repletion and overcoming Malnutrition and 4) improve Body
Mass (and Weight), especially in the elderly and debilitated.
We seeded our algorithm with Somatomedins (C0037657)
and Insulin-Like Growth Factor I (C0021665) as the sources,
and Arginine (C0003765) as the target. The corpus consisted
of more than 11,000 articles (819 on Somatomedins and 10,698
on Arginine (with 53 overlapping), in the pre-April 1989 period.
The path length was set to 2, this time with the STRICT predi-
cate filter. There were 5195 concepts and 17,058 predications
in the predications graph and 239 distinct paths in the candidate
graph. The algorithm terminated in less than one hour produc-
ing 10 subgraphs (and 153 singletons) at 2σ and 7 subgraphs
(and 205 singletons) at 3σ.
Figure 14: Subgraph5 (k = 2, 3σ) Somatomedin C – Arginine
Figure 14 shows the intermediate Growth Hormone in sub-
graph5 at 3σ. The sequence of predications [Arginine STIM-
ULATES Growth Hormone], and [Growth Hormone STIMU-
LATES Somatomedins] is entirely correct and requires no fur-
ther proof (in terms of rediscovery). Still, for verification, we
confirmed in the article [PMID6394628] by Chew et. al. that
dietary Arginine stimulates the release of Growth Hormones.
These Growth Hormones then stimulate the production of So-
matomedin C (IGF1), which leads to cell growth and increased
body size and muscle (i.e., protein synthesis), as noted in article
[PMID7194347] by Clemmons et. al. The same association is
captured in subgraph6 at 2σ (not shown).
In subgraph5, several articles from which the seemingly spu-
rious predication [Arginine TREATS Child] was extracted, upon
investigation, were shown to actually discuss Glucagon and In-
sulin. This includes the article [PMID7204541] by Blethen et.
al. whose title is “Plasma somatomedins in children with hy-
perinsulinism.” Likewise, the article [PMID6205015] by Bi-
noux et. al. from which the predication [Arginine TREATS Rat-
tus norvegicus] was extracted, discusses observations regarding
Insulin-like Growth Factor 1 in the serum of rats. The article
[PMID7007553] by Ashby et. al. from which the same predi-
cation was extracted, discusses the effects of Progesterone and
Insulin in rats, resulting from Glucose and Arginine stimula-
tion. Based on these observations, it is reasonable to conclude
that this subgraph captures the shared context of role of Insulin
in Somatomedin C and Arginine.
Subgraph7 at 3σ (not shown) contains the concept Growth
as an intermediate instead of Growth Hormone (similar to sub-
graph2 at 2σ, also not shown). The sequence of predica-
tions [IGF1 CAUSES Growth] and [Growth PRODUCES So-
matomedins], is interesting because the article [PMID3748655]
by van Buul-Offers et. al. from which the predication [IGF1
CAUSES Growth] was extracted states that IGF1 “increases
body length and weight, as well as the growth of several organs
of Snell dwarf mice,” which is consistent with Swansons re-
port. The association between Malnutrition and Somatomedin
production was found in the article [PMID7023246] by Mc-
Cumbee et. al., from which the predication [Growth PRO-
DUCES Somatomedins], was extracted. No obvious associa-
tion to Wound Healing was found using our methods. Table 4
shows that 3 out of 4 intermediates could be found using our
approach.
Table 4: Comparison of rediscoveries with other approaches for
Somatomedin C - Arginine
Scenario Intermediate(s)
Cameron Srinivasan [7]
S P S P
Somatomedin C - Arginine
Growth Hormone Y 5 Y 1
Body Weight Y* 7 Y 4
Malnutrition Y* 7 – –
Wound healing – – Y 4
3.1.4. Remaining Experiments
This section briefly presents the results for the remaining 6
rediscoveries attempted. Each intermediate marked as redis-
covered was found using predicates, provenance and discovery
browsing as previously done.
Scenario 4: For the Indomethacin - Alzheimer’s Disease dis-
covery [32] by Smalheiser and Swanson in 1995, there were 15
subgraphs at 2σ. Srinivasan found all 8 intermediates, while we
only recovered 6 out of 8 intermediates from subgraphs 2, 3, 4
and 14 (shown in Table 5). Recall that all our subgraphs are all
automatically generated.
Table 5: Comparison of rediscoveries with other approaches in
the literature for Indomethacin - Alzheimer’s Disease
Scenario Intermediate(s)
Cameron Srinivasan [7]
S P S P
Indomethacin -
Alzheimer’s
Disease
Acetylcholine Y 4 Y 2
Lipid peroxidation Y* 2 Y 4
M2-muscarinic – – Y 3
Membrane Fluidity – – Y 10
Lymphocytes Y* 14 Y 4
Thyrotropin Y ZR-20 Y 9
T-lymphocytes (T-Cells) Y* 3 Y 5
Scenario 5: For Estrogen - Alzheimer’s Disease [33] by
Smalheiser and Swanson in 1995, we found 3 out of 8 interme-
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Table 6: Comparison of rediscoveries with other approaches in
the literature for Estrogen - Alzheimer’s Disease
Scenario Intermediate(s)
Cameron
S P
Estrogen - Alzheimer’s Disease
Antioxidant activity Y* 4
Alipoprotein E (ApoE) Y* 3
Calbindin D28k Y 4
Cathepsin D – –
Cytochrome C oxidase – –
Glutamate – –
Receptor Polymorphism – –
Superoxide Dismutase – –
diates from 3 subgraphs at 2σ, as shown in Table 6. Srinivasan
did not attempt this experiment.
Table 7: Comparison of rediscoveries with other approaches in
the literature for Calcium-Independent PLA2 - Schizophrenia
Scenario Intermediate(s)
Cameron Srinivasan [7]
S P S P
Calcium-Independent PLA2 -
Schizophrenia
Oxidative stress Y* 3 Y 3
Selenium Y* 3 – –
Vitamin E Y* 3 – –
Scenario 6: For Calcium-Independent PLA2 - Schizophre-
nia [34] by Smalheiser and Swanson in 1997, our algorithm
produced 10 subgraphs at 2σ, all of which were singletons.
Here, our results are comparable to Srinivasan’s, except that we
are able to retrieve the article [PMID7782894] by Kuo et. al.
deemed crucial to the discovery, through discovery browsing
from singleton2. The seemingly innocuous singleton in sub-
graph2, which states that [Phospholipase A2 INHIBITS Pro-
teins] [Proteins CAUSES Schizophrenia] leads to the article
[PMID7739414 ] by Berry, from which the predication [Pro-
teins CAUSES Schizophrenia] was extracted. The article shows
that the specific protein discussed was the selenium transport
protein Selenoprotein P, as noted by Smalheiser. The article
by Kuo is #4 in the search results of a MEDLINE search for
Phospholipase A2 AND Selenium AND 1865:1997[DP].
Scenario 7: For Chlorpromazine - Cardiac Hypertrophy
[14] by Wren et. al. in 2002, there were 14 subgraphs at
2σ. The intermediate Isoproterenol was found in subgraph12
(as shown in Table 8). The article [PMID6165961] by Rossi
et. al. from which the predication [Chlorpromazine IN-
HIBITS Isoproterenol] was extracted, together with the article
[PMID203365] by Tsang et. al. from which the predication
Table 8: Comparison of rediscoveries with other approaches in
the literature for Chlorpromazine - Cardiac Hypertrophy
Scenario Intermediate(s)
Cameron
S P
Chlorpromazine - Cardiac
Hypertrophy
Calcineurin Y 5
Isoproterenol Y 12
Table 9: Comparison of rediscoveries with other approaches in
the literature for Testosterone - Sleep
Scenario Intermediate(s)
Cameron Goodwin [21]
S P S P
Testosterone - Sleep Cortisol/Hydrocortisone Y 10 Y 4
[Isoproterenol CAUSES Cardiomegaly] was extracted, substan-
tiated these predications. Subgraph5 contained the predications
[Chlorpromazine INHIBITS Calcineurin] extracted from the ar-
ticle [PMID9001710] by Gong et. al. and the predication
[Calcineurin CAUSES Cardiac Hypertrophy] extracted from
several articles, including [PMID9568714, PMID10679475,
PMID11248077, PMID11773940, PMID10189350].
Scenario 8: For Testosterone - Sleep [22] by Miller and
Rindflesch in 2011, which articulates that “testosterone en-
hances sleep quality by inhibiting cortisol,” we found 11 sub-
graphs at 2σ and 10 subgraphs at 3σ. Cortisol (or Hydrocor-
tisone) was found in subgraph7 at 3σ and also in subgraph11
at 2σ. The article [PMID8548511] by Kern et. al. confirmed
that [Hydrocortisone DISRUPTS Sleep], while the crucial ar-
ticle [PMID15841103] by Rubinow et. al., noted by Miller,
confirms that [Testosterone INHIBITS Hydrocortisone].
Scenario 9: For Diethylhexyl Phthalate (DEHP) - Sepsis
[28] by Cairelli and Rindflesch in 2013, which articulates one
possible mechanism for the obesity paradox [38], we did not
find the intermediate PParGamma altogether.
In summary, several approaches succeed in providing au-
tomation for finding intermediates. These approaches leverage
keyword-based, concept-based relations-based, graph-based
and hybrid techniques. Many also provide predicates between
concepts, while more recent approaches are able to substantiate
intermediates with provenance in MEDLINE. The main inno-
vation of our approach is that we are able to retrieve and sub-
stantiate existing discoveries, on different thematic dimensions,
using implicit and explicit context as suggested by Gordon and
Dumais [2], not frequency, graph metrics or specificity. To the
best of our knowledge, an approach that has rediscovered as
many intermediates, with such degree of automation and sub-
stantiation of the knowledge, has never been developed. In the
next section the statistical evaluation is presented.
3.2. Statistical Evaluation
In the previous section, we showed that our context-driven
subgraph method facilitated the rediscovery of 8 existing dis-
coveries with their substantiation in MEDLINE. While these
are encouraging results, one might argue that our experiments
were biased since we knew the intermediates to be found in the
first place. Hence, it was easy to find them in the subgraphs.
A more important question is how interesting are subgraphs in
general, such that an arbitrary domain expert might be moti-
vated to explore them altogether? To address this question, we
conducted a statistical evaluation, which uses association rar-
ity to compute interestingness. If the interestingness score of
the subgraphs across an entire experiment is low, then the re-
discoveries were fortuitous and the associations that led to the
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rediscoveries were serendipitous, rather than systematic. While
this not a complete loss, it is still less than ideal.
To perform this evaluation, for each path in each subgraph
across the 8 rediscoveries (excluding singletons), a PubMed
query was executed using the eUtils Web Service9. This was
used to determine the number of documents that contain the as-
sociation in MEDLINE, with the date restriction enforced. For
example, for the path [Arginine STIMULATES Growth Hor-
mone], [Growth Hormone STIMULATES Somatomedins], the
query “Arginine AND Growth Hormone AND Somatomedins
AND 1865:1989/04[DP]” was composed, where Arginine,
Growth Hormone, and Somatomedins represent an association.
The rarity
r(E) =
∑
pi∈E f (A(pi))
|E|
(10)
of a set of associations across all subgraphs in an experiment
E, is computed as the average of the association rarity, where
f (A(pi)) is the frequency of a unique association in MEDLINE.
The interestingness of an experiment
I(E) =
1
r(E) + 1
(11)
was computed as the normalized reciprocal of rarity.
Table 10 shows the rarity and interestingness scores for each
of the eight successful rediscoveries. For the Raynaud Syn-
drome – Dietary Fish Oils experiment, there were 10 unique
intermediates/associations among the 4 subgraphs at 2 σ, all
of which had a zero-rarity in MEDLINE. This is not surpris-
ing, since Swanson noted in [29] that only four articles from
the Raynaud literature overlapped with the Fish Oil literature
by 1986. The rarity of these subgraphs is therefore 0.00, and
the interestingness is 1 (meaning absolutely interesting).
For Magnesium – Migraine there were 48 unique associa-
tions. The most commonly known intermediates were Hyper-
tensive Disease (3), Individual (3) and Vascular Diseases (4),
respectively among a total of 27 documents. The overall rarity
of the subgraphs in the experiment was therefore 27/48 = 0.56
and the interestingness is 0.64.
For Somatomedin C – Arginine there were 18 unique associa-
tions/intermediates among a total of 306 documents. The most
commonly known intermediates were Child (16), Somatropin
(63) and Growth Hormone (63). There were only two zero-
rarity associations, which were from the intermediates Mus (0)
and Falls (0). Clearly these are not interesting. Not surpris-
ingly, the overall interestingness score of these subgraphs was
306/18 = 17 and the interestingness is low (0.06). This suggests
that this field was better studied than others. It also partially
supports the observation by Gordon and Dumais [2] that while
frequency of intermediates may be sufficient for finding novel
intermediates in some cases, it may be insufficient to capture
the related concepts that elucidate complex associations.
There were 21 unique associations for Indomethacin –
Alzheimers. Hydrogen Peroxide (2), Interleukin-1 (2) and Free
9eUtils Help - http://www.ncbi.nlm.nih.gov/books/NBK25500/
Radicals (3) were the most commonly known intermediates
among a total of 9 documents. The overall rarity score was
9/21 = 0.43 and the interestingness is 0.70.
For Estrogen – Alzheimers there were 42 unique associations,
with 36 zero-rarity associations. Metabolism (6), Dementia
(10) and Senile dementia (10) were the most commonly known
intermediates among a total of 36 documents. The rarity score
is 36/42 = 0.86 and the interestingness is 0.54.
For Calcium-Independent PLA2 – Schizophrenia there were
10 unique intermediates/associations (singletons described in
Section 4.1.6), each of which was zero-rarity. Hence, the rarity
of this subgraph is 0.00 and the interestingness was high (1.0).
For Chlorpromazine – Cardiac Hypertrophy there were 21
unique associations, and 19 at zero-rarity. The most commonly
known were Catecholamines (1) and Hypertensive disease (1)
among a total of 2 documents. The rarity is therefore 2/21 =
0.10 and the interestingness is high (0.91).
For Testosterone – Sleep, there were 61 unique association-
s/intermediates and 20 at zero-rarity. The most commonly
known were Proteins (63), Symptoms (91) and Hormones (207)
among a total of 654 documents. The overall rarity score was
therefore 654/61 = 10.72 and the interestingness is low (0.09).
This is not surprising, since these two domains (Testosterone
and Sleep) are fairly well studied. This is another scenario that
suggests frequency may not be as effective for finding the re-
lated concepts that elucidate complex associations.
Across all 8 rediscoveries, the average rarity score is there-
fore 3.71 and the average interestingness was 0.62. This sug-
gests that an association chosen at random from the rediscover-
ies is likely to be known to only approximately 4 documents in
MEDLINE. Such a low rarity score suggests that the subgraphs
themselves might be quite interesting to a domain expert. This
is however not surprising, since most of the discoveries, at the
time when made would have been inherently interesting situ-
ations and possibly not well studied in the literature. Testos-
terone – Sleep (2011) and Somatomedin C – Arginine (1990)
are exceptional.
4. Discussion
This paper showed that the use of implicit and explicit con-
text to find and elucidate associations among concepts along
multiple thematic dimensions is effective for LBD. However,
our approach has several limitations. The first limitation is
the assumption that the context of a semantic predication, ex-
pressed in terms of the distribution of MeSH descriptors is re-
liable for generating meaningful subgraphs. Not all MeSH de-
scriptors assigned to an article are relevant to all its semantic
predications, and hence the predication context vectors could
be noisy. Ideally, direct mappings between semantic predica-
tions and MeSH descriptors could help resolve this discrepancy.
Since, such mappings are unavailable our specification of con-
text is subject to limitations of distributional semantics.
The second limitation is the degree of domain expertise still
required for discovery browsing. Although impractical to elim-
inate the need for domain expertise, one improvement would be
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Table 10: Rarity and Interestingness score of the subgraphs in the rediscoveries
Experiment # Unique Associations MEDLINE Frequency r(E) I(E)
Raynaud Syndrome - Dietary Fish Oils 10 0 0.00 1.00
Magnesium - Migraine 48 27 0.56 0.64
Somatomedin C - Arginine 18 306 17.00 0.06
Indomethacin - Alzheimer’s Disease 21 9 0.43 0.70
Estrogen - Alzheimer’s Disease 42 36 0.86 0.54
Calcium Independent PLA2 - Schizophrenia 10 0 0.00 1.00
Chlorpromazine - Cardiac Hypertrophy 21 2 0.10 0.91
Testosterone - Sleep 61 654 10.72 0.09
Average 29 129 3.71 0.62
providing additional background knowledge to supplement the
subgraphs where appropriate. In this way, assertional knowl-
edge from the literature would be complemented with defini-
tional knowledge from structured knowledge sources (though
deep integration). Metrics for determining interesting neigh-
boring concepts in background knowledge need to be developed
for concepts in the subgraph to overcome this limitation.
Another limitation is the inability to systematically detect
contradicting semantic predications. While the provenance of
predications in MEDLINE allows domain experts to adjudicate,
a method for resolving conflicting predications could be bene-
ficial. We believe that temporal analysis of semantic predica-
tions could enable conflict resolution. However, since many
unresolved paradoxes inherent in science itself are reported in
the literature, it is unclear whether one might reliably detect
and resolve such contradictions automatically, using temporal,
statistical and/or semantic approaches.
The reliability of the statistical evaluation is also another lim-
itation of our approach. Rare associations are generally inter-
esting but not always. While alternative methods for conduct-
ing statistical evaluation for LBD have been discussed [39], it
is cumbersome to coordinate cut-off dates for each predication
across the rediscoveries. The suggested techniques are there-
fore impractical to implement. We use association rarity to in-
dicate interestingness, similar to existing research [20, 7].
A number of technical limitations exist in our approach. The
first technical limitation is the manual selection of a threshold
for MeSH semantic similarity based on dice similarity. While
dice is advantageous because it is easy to implement, other
similarity metrics and more principled ways of computing the
threshold should be explored. Likewise, the threshold for path
relatedness, which is based on the second (and third) standard
deviation from the mean of the Gaussian distribution, could be
unreliable. Our results show that the data distributions only ap-
proximate to Gaussian. The p-values from the χ2 test of the
three Gaussian distribution in Figure 4 indeed more than the
0.05 value normally considered acceptable. To overcome this
limitation, we anticipate that path relatedness could be recom-
puted relative to the minimum relatedness score. Torvik et. al.
[12] and Smalheiser et. al. [15] implemented an approach based
loosely on this idea, which normalized the distribution, using a
mixture of Gaussian models.
Across some experiments, we utilized predicate filters
to eliminate non-informative relationships (such as ASSOCI-
ATED WITH, INTERACTS WITH, AFFECTS, etc). This is a compro-
mise to achieve scalability. Ideally, the system should not re-
quire any predicate filters. In fact, the omission of some pred-
icates may be responsible for low recall in some of our experi-
ments. Still, given that most experiments terminated in less than
one hour, higher recall may not be too costly for performance.
With the emergence of big data infrastructure, the performance
limitations of our clustering may be resolved using additional
computational resources.
The choice of HAC could be considered another limitation.
HAC was selected because it is an unsupervised, deterministic
clustering algorithm, for which the number of clusters does not
have to be known or specified a priori. The time complexity of
HAC is Θ(N2 log N) in the best case. While approaches, such as
those by Ramakrishnan et. al. [20] and van der Eijk et. al. [23]
may be applicable for subgraph creation, it is unclear how they
might be adapted to generate complex subgraphs along multiple
thematic dimensions.
These and other limitations suggest the next steps in this re-
search. In future, labels for subgraphs should be provided. This
is a crucial task, since our approach is predicated on the idea
that each subgraph captures a different thematic dimension of
association between two concepts. Additionally, a comparative
study using full text, compared to titles and abstracts, could be
useful. However, full text is only available on a limited scale.
5. Conclusion
Leveraging rich representations of textual content from
scientific literature based on implicit and explicit context
can provide effective means for literature-based discov-
ery, as illustrated in this paper. This paper also shows
that these rich representations were important in facilitat-
ing the rediscovery of 8 out of 9 well-known associations
and their substantiation. The approach advances LBD re-
search specifically because it uses notions of context and
shared context to facilitate making discoveries from scien-
tific literature, which do not rely on statistical frequency,
graph metrics or specificity. A beta-version of the Obvio
web application is available online for optional view-
ing (http://knoesis-hpco.cs.wright.edu/obvio/),
along with various other resources (wiki page -
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http://wiki.knoesis.org/index.php/Obvio, video
demo - http://bit.ly/obviodemo), which help put the
contributions of this research into perspective.
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